Images for illustrative purposes only - Wegovy is the licensed version of semaglutide for weight loss. This product page is intended to inform customers.

How it works?

Online Consultation

We ask you to complete a quick and easy consultation and get you started.

Choose condition

We have a selection of treatments available for various conditions.

Express Delivery

You will have complete visibility and control of your delivery.
Notice!

Before ordering this treatment, you may have to complete an online consultation

Overview

Ozempic (semaglutide) is a once-weekly injectable treatment licensed for type 2 diabetes. It contains semaglutide, a GLP-1 receptor agonist that works by lowering blood sugar and supporting healthy weight management in people with type 2 diabetes. It slows digestion, reduces appetite, and helps the body regulate insulin more effectively.

Although Ozempic is primarily prescribed for diabetes, many patients taking it also notice a reduction in weight. This is because semaglutide works on the same appetite and satiety pathways in the brain that are targeted in newer weight loss medicines.

In fact, semaglutide is also the active ingredient in Wegovy, which is licensed specifically for weight management. While Ozempic and Wegovy are prescribed for different conditions, they both work in a very similar way inside the body.

At SwiftMedi, your treatment is supplied after a secure online consultation with a UK-registered prescriber, dispensed from our UK-regulated pharmacy, and delivered quickly and discreetly to your door.

Directions

Administration: Injected once a week under the skin (abdomen, thigh, or upper arm).


Dosing schedule: Usually starts at 0.25mg weekly, gradually increasing under prescriber guidance.


Ease of use: Pre-filled pens make self-injection straightforward and safe.


Duration: Ozempic is intended for long-term use in type 2 diabetes management.

Side Effects

Like all medicines, Ozempic can cause side effects, although not everyone experiences them. Most are mild and temporary.

Common (may affect up to 1 in 10 people):

  • Nausea or feeling sick
  • Diarrhoea or constipation
  • Reduced appetite
  • Indigestion or bloating


Less common (may affect up to 1 in 100 people):

  • Vomiting
  • Abdominal pain
  • Fatigue
  • Redness or itching at the injection site


Rare but serious (seek urgent medical help):

  • Severe abdominal pain (possible pancreatitis)
  • Signs of allergic reaction (rash, swelling, difficulty breathing)


Disclaimer: This is not a complete list of side effects. Always read the patient information leaflet before use. If you notice anything unusual or concerning, seek medical advice promptly. In an emergency, call 999 or go to A&E.

Warnings

Ozempic may not be suitable for everyone. You should not use it if you:

  • Have a personal or family history of medullary thyroid cancer
  • Have multiple endocrine neoplasia syndrome type 2 (MEN2)
  • Are pregnant or breastfeeding
  • Have severe gastrointestinal disease or pancreatitis

Always complete your consultation truthfully so your prescriber can ensure treatment is safe for you.

FAQ's

What is Ozempic used for?
Ozempic is licensed for the treatment of type 2 diabetes, helping control blood sugar levels while also reducing appetite and supporting weight management.

Is Ozempic the same as Wegovy?
Both contain the same active ingredient — semaglutide — but are licensed for different purposes. Wegovy is approved specifically for weight management, while Ozempic is licensed for type 2 diabetes.

Can Ozempic help with weight loss?
Although licensed for diabetes, many patients using Ozempic also notice significant weight loss, as it works on the same appetite pathways as weight loss treatments.

How is Ozempic taken?
It is injected once weekly under the skin using a pre-filled pen. The dose is gradually increased under prescriber supervision.

Is Ozempic safe for long-term use?
Yes. Ozempic has been studied extensively and is considered safe and effective when prescribed appropriately and monitored by a prescriber.